AdaptHealth appointed Harriss Currie as chief financial officer with an annual base salary of $670,000, a target Bonus equal to 100% of salary and $818,462 in restricted stock units. Investors now have defined compensation, equity-vesting and separation terms as Jason Clemens leaves the CFO role during 2026.
Key Highlights
- AdaptHealth will grant Currie restricted stock units valued at $818,462.
- Jason Clemens will end his employment with AdaptHealth on October 1, 2026.
- Harriss Currie’s appointment as chief financial officer is effective September 9, 2026.
AdaptHealth Corp. (NASDAQ: AHCO) appointed Harriss Currie as chief financial officer, with an annual base salary of $670,000. Jason Clemens will leave the CFO position during 2026 and terminate his employment with AdaptHealth later in the year.
Restricted Stock Units and Employment Terms
Currie received restricted stock units valued at $818,462. Under the qualifying termination provisions, he is entitled to earned unpaid bonuses, continued base-salary payments and health-insurance coverage. The agreement also contains non-compete, non-solicit, confidentiality, invention-assignment and non-disparagement covenants.
Clemens’ authority to act as CFO ends during 2026. His employment, however, terminates later that year, and he will receive severance and other benefits under the terms of his employment agreement.
FAQs
Q: Who is AdaptHealth’s new chief financial officer?
A: Harriss Currie has been appointed AdaptHealth’s chief financial officer. His compensation includes a $670,000 annual base salary and eligibility for an incentive bonus.
Q: What is Harriss Currie’s target bonus at AdaptHealth?
A: Currie’s target annual incentive bonus is 100% of his base salary. The actual bonus depends on achievement of annual performance objectives, and his 2026 bonus will be prorated subject to continued employment through the payment date.
Q: What equity award will AdaptHealth give Harriss Currie?
A: AdaptHealth will grant Currie restricted stock units valued at $818,462. 50% will vest through annual installments, with the remaining 50% vesting in a single installment.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.